Go Pro

Relmada Therapeutics (RLMD) Short Interest Ratio & Short Volume

Relmada Therapeutics logo
$4.63 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

Relmada Therapeutics Short Interest Overview

As of July 31, 2026, Relmada Therapeutics (RLMD) had a short interest of 13.56 million shares sold short, representing 14.87% of the public float. This marks a 4.41% increase in short interest since the prior report. The short interest ratio (days to cover) is 7.8, meaning it would take 7.8 days of the average trading volume of 1.23 million shares to cover all short positions.

Current Short Interest
13,563,773 shares
Previous Short Interest
12,990,487 shares
Change Vs. Previous Month
4.41%
Dollar Volume Sold Short
$72.02 million
Short Interest Ratio
7.8 Days to Cover
Last Record Date
July 31, 2026
Outstanding Shares
106,670,000 shares
Short Percent of Float
14.87%
Today's Trading Volume
985,172 shares
Average Trading Volume
1,230,305 shares
Today's Volume Vs. Average
80%
Short Selling Relmada Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Relmada Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

RLMD Short Interest Over Time

RLMD Days to Cover Over Time

RLMD Percentage of Float Shorted Over Time

Relmada Therapeutics Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202613,563,773 shares $72.02 million +4.4%14.9%7.79 $5.31
7/15/202612,990,487 shares $80.67 million +22.0%14.5%8.46 $6.21
6/30/202610,647,441 shares $73.68 million +75.7%11.9%3.07 $6.92
6/15/20266,060,018 shares $38.60 million +3.8%6.8%4.43 $6.37
5/29/20265,841,074 shares $42.11 million +6.4%6.5%6.07 $7.21
5/15/20265,487,630 shares $37.86 million +2.6%6.1%6.11 $6.90
4/30/20265,348,739 shares $40.22 million -13.6%6.0%3.87 $7.52
4/15/20266,193,292 shares $44.47 million +2.5%6.9%4.78 $7.18
3/31/20266,042,204 shares $42.05 million +61.9%6.7%4.45 $6.96
3/13/20263,731,201 shares $22.05 million +346.2%6.4%0.74 $5.91
2/27/2026836,254 shares $3.81 million -24.8%1.4%1.27 $4.56
2/13/20261,111,415 shares $4.13 million -11.5%1.2%1.96 $3.72
1/30/20261,256,360 shares $4.46 million -12.3%2.2%2.29 $3.55
1/15/20261,433,056 shares $5.45 million +3.2%2.5%2.75 $3.80
12/31/20251,388,226 shares $6.71 million +41.6%2.4%1.57 $4.83
12/15/2025980,736 shares $4.28 million +26.9%1.7%0.9 $4.36
11/28/2025772,889 shares $3.49 million -18.3%1.3%0.77 $4.51
11/14/2025946,511 shares $3.74 million +84.1%1.6%0.28 $3.95
10/31/2025514,106 shares $1.16 million -8.6%2.0%3.11 $2.26
10/15/2025562,400 shares $1.16 million -32.7%2.1%0.8 $2.07
9/30/2025835,700 shares $1.68 million +17.5%N/A1.1 $2.01
9/15/2025711,300 shares $1.19 million +27.6%N/A1 $1.67
8/31/2025557,300 shares $624.18 thousand +16.5%2.1%0.8 $1.12
8/15/2025478,400 shares $309.09 thousand +19.2%N/A1.5 $0.65
7/31/2025401,300 shares $249.77 thousand -5.3%1.5%0.9 $0.62
7/15/2025423,900 shares $267.90 thousand -28.8%N/A0.2 $0.63
6/30/2025595,000 shares $357.18 thousand -14.5%2.3%0.3 $0.60
6/15/2025695,500 shares $486.99 thousand -38.5%2.6%0.4 $0.70
5/31/20251,130,000 shares $814.05 thousand -7.4%4.6%0.6 $0.72
5/15/20251,220,000 shares $504.35 thousand -39.9%4.9%0.7 $0.41
4/30/20252,030,000 shares $654.47 thousand +44.0%N/A1 $0.32
4/15/20251,410,000 shares $434.28 thousand -13.0%5.7%0.8 $0.31
3/31/20251,620,000 shares $437.40 thousand +8.7%6.5%1.7 $0.27
3/15/20251,490,000 shares $436.12 thousand +18.3%6.0%1.4 $0.29
2/28/20251,260,000 shares $327.60 thousand -28.0%5.1%0.8 $0.26
2/15/20251,750,000 shares $582.58 thousand +108.8%7.1%1.1 $0.33
1/31/2025838,000 shares $292.46 thousand -33.0%N/A0.6 $0.35
1/15/20251,250,000 shares $495.63 thousand -24.2%N/A1.3 $0.40
12/31/20241,650,000 shares $858 thousand -7.3%N/A1.7 $0.52
12/15/20241,780,000 shares $653.26 thousand +67.9%N/A2.3 $0.37
A Simple Guide to Options Trading While It's Still Free (Ad)

A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe calls it The 10-Minute Guide to Start Trading Options Today, built to help you open your first options trade with less capital than buying shares outright.tc pixel

Download your free copy of Options Trading Made Simple before it's gone
11/30/20241,060,000 shares $3.20 million -7.8%N/A1.6 $3.02
11/15/20241,150,000 shares $3.46 million -3.4%N/A6.1 $3.01
10/31/20241,190,000 shares $4.14 million -5.6%N/A6.7 $3.48
10/15/20241,260,000 shares $4.38 million +0.8%N/A6.9 $3.48
9/30/20241,250,000 shares $4.05 million +5.9%N/A6.6 $3.24
9/15/20241,180,000 shares $3.65 million -2.5%N/A6.6 $3.09
8/31/20241,210,000 shares $3.39 million -6.2%N/A10.8 $2.80
8/15/20241,290,000 shares $3.32 million -3.0%N/A11.5 $2.57
7/31/20241,330,000 shares $4.87 million -2.2%N/A12.2 $3.66
7/15/20241,360,000 shares $5.22 million +34.7%N/A13.1 $3.84
6/30/20241,010,000 shares $3.03 million -34.8%N/A9.6 $3.00
6/15/20241,550,000 shares $4.67 million +0.7%N/A14.9 $3.01
5/31/20241,540,000 shares $4.62 million -1.9%N/A11.1 $3.00
5/15/20241,570,000 shares $5.46 million -4.3%N/A10.6 $3.48
4/30/20241,640,000 shares $5.97 million -4.1%N/A9.4 $3.64
4/15/20241,710,000 shares $7.61 million +1.2%N/A8.1 $4.45
3/31/20241,690,000 shares $7.86 million -3.4%N/A7.4 $4.65
3/15/20241,750,000 shares $9.49 million No ChangeN/A5.4 $5.42
2/29/20241,750,000 shares $10.72 million +1.2%N/A5.5 $6.13
2/15/20241,730,000 shares $9.12 million +7.5%N/A5.6 $5.27
1/31/20241,610,000 shares $6.33 million +3.2%N/A5.6 $3.93
1/15/20241,560,000 shares $4.90 million +92.4%N/A6.3 $3.14
12/31/2023810,700 shares $3.36 million +26.9%N/A3.3 $4.14
12/15/2023638,800 shares $1.58 million -26.2%N/A3.7 $2.48
11/30/2023865,800 shares $2.14 million -1.1%N/A5.3 $2.47
11/15/2023875,200 shares $2.65 million +10.1%N/A5.6 $3.03
10/31/2023794,700 shares $2.38 million +13.4%N/A5 $2.99
10/15/2023700,900 shares $2.17 million -2.5%N/A4.6 $3.10
9/30/2023718,700 shares $2.16 million +6.1%N/A4.9 $3.00
9/15/2023677,500 shares $2.09 million +9.7%N/A4.5 $3.09
8/31/2023617,700 shares $2.09 million -10.5%N/A3.8 $3.38
8/15/2023689,800 shares $2.35 million -18.8%N/A4.1 $3.41
7/31/2023849,900 shares $2.23 million -11.0%N/A4.8 $2.62
7/15/2023954,400 shares $2.71 million -9.1%N/A5 $2.84
6/30/20231,050,000 shares $2.58 million -46.7%N/A5.2 $2.46
6/15/20231,970,000 shares $5.02 million -5.3%N/A8.7 $2.55
5/31/20232,080,000 shares $5.91 million +16.9%N/A11.3 $2.84
5/15/20231,780,000 shares $5.50 million -3.3%N/A9.1 $3.09
4/30/20231,840,000 shares $4.64 million +0.6%N/A9.1 $2.52
4/15/20231,830,000 shares $4.96 million +4.0%N/A8.5 $2.71
3/31/20231,760,000 shares $3.98 million +13.6%N/A6.6 $2.26
3/15/20231,550,000 shares $3.97 million +6.2%N/A5 $2.56
2/28/20231,460,000 shares $5.26 million -8.8%N/A2.5 $3.60
2/15/20231,600,000 shares $5.94 million No ChangeN/A2.5 $3.71
1/31/20231,600,000 shares $6.50 million -20.4%N/A2.2 $4.06
1/15/20232,010,000 shares $8.28 million +12.3%N/A2.4 $4.12
12/30/20221,790,000 shares $6.25 million +4.1%N/A1.4 $3.49
12/15/20221,720,000 shares $5.40 million -13.6%N/A1.3 $3.14
11/30/20221,990,000 shares $9.25 million -28.2%N/A1.6 $4.65
11/15/20222,770,000 shares $16.32 million -4.2%N/A2.6 $5.89
Buy THIS potential Musk supplier before Wednesday (Ad)

A little-known company trading under $1 could become Elon Musk's next supplier, with a possible announcement expected by Wednesday, August 26. Tech investing veteran Jeff Brown notes that the last time Musk struck a deal with a small company in this sector, the stock soared nearly five times in a single session. He has reopened his strategy session with full details on this potential opportunity.tc pixel

Watch Jeff Brown's urgent strategy session before the Wednesday deadline
10/31/20222,890,000 shares $18.47 million -13.7%N/A2.9 $6.39
10/15/20223,350,000 shares $20.77 million -26.2%N/A3.8 $6.20
9/30/20224,540,000 shares $168.07 million +25.1%N/A12.3 $37.02
9/15/20223,630,000 shares $124.84 million +11.7%N/A11.3 $34.39
8/31/20223,250,000 shares $94.71 million +3.2%N/A11.9 $29.14
8/15/20223,150,000 shares $91.79 million +1.0%N/A12.3 $29.14
7/31/20223,120,000 shares $79.87 million +1.0%N/A12.1 $25.60
7/15/20223,090,000 shares $69.43 million -4.9%N/A11.7 $22.47
6/30/20223,250,000 shares $61.72 million +21.7%N/A12 $18.99
6/15/20222,670,000 shares $44.59 million +1.1%N/A9.5 $16.70
5/31/20222,640,000 shares $49.61 million +21.1%N/A9.2 $18.79
5/15/20222,180,000 shares $43.16 million +32.9%N/A6.6 $19.80
4/30/20221,640,000 shares $41.18 million -4.7%N/A5.1 $25.11
4/15/20221,720,000 shares $44.77 million -4.4%N/A5.5 $26.03
3/31/20221,800,000 shares $48.58 million +23.3%N/A5.9 $26.99
3/15/20221,460,000 shares $32.49 million -11.0%N/A5.2 $22.25
2/28/20221,640,000 shares $33.64 million +34.4%N/A5.9 $20.51
2/15/20221,220,000 shares $24.40 million -8.3%N/A5.1 $20.00
1/31/20221,330,000 shares $24.46 million -21.3%N/A6.6 $18.39
1/15/20221,690,000 shares $33.56 million +24.3%10.7%10 $19.86
12/31/20211,360,000 shares $30.64 million +40.7%8.6%8.6 $22.53
12/15/2021966,900 shares $19.51 million +7.7%6.1%7.1 $20.18
11/30/2021897,600 shares $16.03 million +2.9%5.7%8.2 $17.86
11/15/2021872,400 shares $19.79 million -2.8%5.5%9.2 $22.69
10/29/2021897,500 shares $21.06 million -5.9%5.7%8.2 $23.47
10/15/2021953,300 shares $22.53 million -4.3%6.1%4.1 $23.63
9/30/2021996,200 shares $26.11 million -2.3%6.3%4.1 $26.21
9/15/20211,020,000 shares $27.31 million -1.0%6.5%4.2 $26.77
8/31/20211,030,000 shares $24.63 million +12.1%6.6%4.4 $23.91

RLMD Short Interest - Frequently Asked Questions

Short interest is the volume of Relmada Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 13,563,773 shares of RLMD short. 14.87% of Relmada Therapeutics' shares are currently sold short. Learn More on Relmada Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLMD shares currently have a short interest ratio of 7.8. Learn More on Relmada Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.87% of Relmada Therapeutics' floating shares are currently sold short.

Relmada Therapeutics saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 13,563,773 shares, an increase of 4.4% from the previous total of 12,990,487 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

14.87% of Relmada Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceuticals" compare to Relmada Therapeutics: GH Research PLC (3.69%), Compass Pathways PLC Sponsored ADR (10.40%), Perrigo Company plc (16.75%), ANI Pharmaceuticals, Inc. (11.17%), Avalyn Pharma Inc. (4.55%), Eton Pharmaceuticals, Inc. (5.74%), Xeris Biopharma Holdings, Inc. (5.58%), LB Pharmaceuticals Inc (17.57%), Innoviva, Inc. (9.53%), Harrow, Inc. (20.87%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.50 billion), Invesco QQQ ($50.36 billion), iShares Russell 2000 ETF ($21.20 billion), Western Digital Corporation ($13.40 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($11.46 billion), iShares 20+ Year Treasury Bond ETF ($7.84 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.51 billion), iShares Semiconductor ETF ($6.37 billion), and Financial Select Sector SPDR Fund ($6.34 billion). View all of the most shorted stocks.

Short selling RLMD is an investing strategy that aims to generate trading profit from Relmada Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Relmada Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RLMD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLMD, twice per month. The most recent reporting period available is July, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like RLMD:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NASDAQ:RLMD is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/11/2026. FINRA publishes updated short interest twice a month.
From Our Partners